206 results
Page 3 of 11
424B5
my1v1g3qff
26 Jan 21
Prospectus supplement for primary offering
5:11pm
8-K
EX-1.1
nzpvvy4b6i1h
26 Jan 21
Seelos Therapeutics Announces Pricing of $31.25 Million Public Offering of Common Stock
5:09pm
424B5
4xbnt
25 Jan 21
Prospectus supplement for primary offering
4:16pm
8-K
EX-10.1
0q5ixx939ji0sfhr5
17 Dec 20
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-4.1
ilkfb3
17 Dec 20
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-10.2
5whzn8k77q
9 Sep 20
Seelos Therapeutics Announces Closing of $7.0 Million Registered Direct Offering
4:02pm
8-K
EX-10.1
46t88y0 kcfnrvc8
9 Sep 20
Seelos Therapeutics Announces Closing of $7.0 Million Registered Direct Offering
4:02pm
424B5
ikydb25a78jkv 94
12 Mar 20
Prospectus supplement for primary offering
5:27pm
8-K
EX-1.1
pj239exh2cta2y5f7r
12 Mar 20
Seelos Therapeutics Announces Pricing of $4.5 Million Public Offering of Common Stock
5:24pm
424B4
wa5 2jicu7wn61
11 Feb 20
Prospectus supplement with pricing info
5:14pm
8-K
EX-1.1
bv4n4zxxvgbc5 0s
11 Feb 20
Seelos Therapeutics Announces Pricing of $5 Million Public Offering of Common Stock
6:08am